Viridian Therapeutics, Inc.

VRDN · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$169,647$117,324$116,215$99,594
Short-Term Investments$321,254$446,032$520,418$617,990
Receivables$70,000$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$11,012$15,394$20,605$20,877
Total Curr. Assets$571,913$578,750$657,238$738,461
Property Plant & Equip (Net)$3,707$3,068$3,254$3,441
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$1,518$506$489$501
Total NC Assets$5,225$3,574$3,743$3,942
Other Assets$0$0$0$0
Total Assets$577,138$582,324$660,981$742,403
Liabilities
Payables$10,063$8,518$3,886$2,143
Short-Term Debt$730$8,988$536$513
Tax Payable$0$0$0$0
Deferred Revenue$372$288$288$288
Other Curr. Liab.$39,531$34,791$29,017$44,930
Total Curr. Liab.$50,696$52,585$33,727$47,874
LT Debt$23,090$12,353$20,685$20,582
Deferred Rev, NC$0$140$212$284
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$382$2,077$1,884$2,024
Total NC Liab.$23,472$14,570$22,781$22,890
Other Liabilities$0$0$0$0
Cap. Leases$2,200$553$536$513
Total Liabilities$74,168$67,155$56,508$70,764
Equity
Pref Stock$188,885$188,885$188,885$188,885
Common Stock$822$817$816$810
Retained Earnings-$1,218,103-$1,183,504-$1,082,769-$995,857
AOCI$363$69$245-$10
Other Equity$1,531,003$1,508,902$1,497,296$1,477,811
Total Equity$502,970$515,169$604,473$671,639
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$577,138$582,324$660,981$742,403
Net Debt-$145,827-$95,983-$94,994-$78,499
Viridian Therapeutics, Inc. (VRDN) Financial Statements & Key Stats | AlphaPilot